Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy.
Zhang A, Sun Y, Wang S, Du J, Gao X, Yuan Y, Zhao L, Yang Y, Xu L, Lei Y, Duan L, Xu C, Ma L, Wang J, Hu G, Chen H, Wang Q, Hu L, Zhang B.
Zhang A, et al. Among authors: wang j, wang s, wang q.
Cytotherapy. 2020 Dec;22(12):734-743. doi: 10.1016/j.jcyt.2020.05.007. Epub 2020 Jul 17.
Cytotherapy. 2020.
PMID: 32684339